All Stories

  1. How multidisciplinary teams matter in public health expertise: A case study on the 2023 French infectious disease prioritization exercise
  2. Interplay Between Oral Microbiota and Mouth Health in People Living With HIV Under Antiretroviral Therapy With or Without Periodontitis
  3. Predictive Factors of Cytomegalovirus Colonic Reactivation in Patients with Active Ulcerative Colitis
  4. Impaired mucosal IgA response in patients with severe COVID-19
  5. Combining SARS‐CoV‐2 interferon‐gamma release assay with humoral response assessment to define immune memory profiles
  6. Evaluating the Knowledge of and Behavior Toward COVID-19 and the Possibility of Isolating at a City Level: Survey Study
  7. Human immunodeficiency virus and oral microbiota: mutual influence on the establishment of a viral gingival reservoir in individuals under antiretroviral therapy
  8. First RSV epidemic with nirsevimab. Older children than previous epidemics, even when hospitalized
  9. HIV‐Infected Individuals Do Not Present Significant Differences regarding Periodontal Status: A Systematic Review and Meta‐Analysis
  10. Molecular testing for human immunodeficiency virus
  11. Agents associated with sexually transmitted infections
  12. Factors Contributing to Delayed Return to Work among French Healthcare Professionals Afflicted by COVID-19 at a Hospital in the Rhône-Alpes Region, 2021
  13. Prospective Evaluation of the BD MAX StaphSR Assay for the Screening of Methicillin-Susceptible and -Resistant Staphylococcus aureus from Nasal Swabs Taken in Intensive Care Unit Patients
  14. Arboviral Risk Associated with Solid Organ and Hematopoietic Stem Cell Grafts: The Prophylactic Answers Proposed by the French High Council of Public Health in a National Context
  15. Ultrafast inactivation of SARS-CoV-2 by 254-nm UV-C irradiation on porous and non-porous media of medical interest using an omnidirectional chamber
  16. Arboviral Risk Associated with Solid Organ and Hematopoietic Stem Cell Grafts: The Prophylactic Answers Proposed by the French High Council of Public Health in a National Context
  17. Extended safety and tolerability of subcutaneous CAP256V2LS and VRC07-523LS in HIV-negative women: study protocol for the randomised, placebo-controlled double-blinded, phase 2 CAPRISA 012C trial
  18. Long-term humoral response following Delta and Omicron BA.1 co-infection
  19. Effect of Non-Surgical Periodontal Therapy on Clinical Parameters of Periodontitis, Oral Candida spp. Count and Lactoferrin and Histatin Expression in Saliva and Gingival Crevicular Fluid of HIV-Infected Patients
  20. A third vaccine dose equalises the levels of effectiveness and immunogenicity of heterologous or homologous COVID-19 vaccine regimens, Lyon, France, December 2021 to March 2022
  21. Staphylococcus aureus nasal colonization level and intracellular reservoir: a prospective cohort study
  22. Prior SARS-CoV-2 infection enhances and reshapes spike protein–specific memory induced by vaccination
  23. Evaluating the Knowledge of and Behavior Toward COVID-19 and the Possibility of Isolating at a City Level: Survey Study (Preprint)
  24. A third vaccine dose equalizes the levels of effectiveness and immunogenicity of heterologous or homologous COVID-19 vaccine regimens
  25. Determinants of protection against SARS-CoV-2 Omicron BA.1 and Delta infections in fully vaccinated outpatients
  26. Evaluation of the BL-RED (Beta-Lactamase Rapid Electrochemical Detection) test for the rapid detection of resistance to third-generation cephalosporins in Enterobacteriaceae
  27. Management of patients with monkeypox virus infection and contacts in the community and in healthcare settings: a French position paper
  28. Evaluation of Rapid Lateral-Flow Tests Directed against the SARS-CoV-2 Nucleoprotein Using Viral Suspensions Belonging to Different Lineages of SARS-CoV-2
  29. Impact of Dextran-Sodium-Sulfate-Induced Enteritis on Murine Cytomegalovirus Reactivation
  30. Dynamics of viral shedding during ancestral or Omicron BA.1 SARS-CoV-2 infection and enhancement of pre-existing immunity during breakthrough infections
  31. Monitoring of Both Humoral and Cellular Immunities Could Early Predict COVID-19 Vaccine Efficacy Against the Different SARS-CoV2 Variants
  32. Evaluation of commercial Anti-SARS-CoV-2 neutralizing antibody assays in seropositive subjects
  33. SARS-CoV-2 rapid test versus RT-qPCR on noninvasive respiratory self-samples during a city mass testing campaign.
  34. Nurses’ Influenza Vaccination and Hesitancy: A Systematic Review of Qualitative Literature
  35. Are Anti-Receptor–Binding Domain Antibodies Still a Relevant Proxy for Monitoring SARS-CoV-2 Neutralizing Activity in the Omicron Era?
  36. Prospective evaluation of the point-of-care use of a rapid antigenic SARS-CoV-2 immunochromatographic test in a paediatric emergency department
  37. Effect of influenza vaccination among healthcare workers on hospital-acquired influenza in short-stay hospitalized patients: A multicenter pilot study in France
  38. Rhabdomyolyse avec tétraparésie secondaire à une hépatite virale E chez un patient sous statines
  39. Gingival tissue as a reservoir for human immunodeficiency virus type 1: Preliminary results of a cross‐sectional observational study
  40. Development and Validation of the COVID-19 Knowledges and Behavior Questionnaire in a French Population (CoVQuest-CC)
  41. Non‐surgical periodontal debridement affects subgingival bacterial diversity in patients with HIV‐1 and periodontitis
  42. Evaluation of the MRSA/SA ELITe MGB Assay for the Detection of Staphylococcus aureus in Bone and Joint Infections
  43. Evaluation of Commercial Anti-SARS-CoV-2 Neutralizing Antibody Assays in seropositive subjects
  44. CAPRISA 018: a phase I/II clinical trial study protocol to assess the safety, acceptability, tolerability and pharmacokinetics of a sustained-release tenofovir alafenamide subdermal implant for HIV prevention in women
  45. Dépistage et tests Covid-19
  46. Evaluation of in vitro activity of copper gluconate against SARS-CoV-2 using confocal microscopy-based high content screening
  47. Gestion des alertes arbovirales : retour d’expérience du groupe de travail Secproch du Haut Conseil de la santé publique (2019–2021)
  48. Immunogenicity and efficacy of          heterologous ChAdOx1–BNT162b2 vaccination
  49. Evidence of HIV-1 Genital Shedding after One Year of Antiretroviral Therapy in Females Recently Diagnosed in Bamako, Mali
  50. Impact of Host Immune Status on Discordant Anti-SARS-CoV-2 Circulating B Cell Frequencies and Antibody Levels
  51. Publisher Correction: Clinical and laboratory characteristics of symptomatic healthcare workers with suspected COVID-19: a prospective cohort study
  52. Role of hepatitis C virus core antigen assay in hepatitis C care in developing country
  53. Specific detection of memory T‐cells in COVID‐19 patients using standardized whole‐blood Interferon gammarelease assay
  54. Clinical and laboratory characteristics of symptomatic healthcare workers with suspected COVID-19: a prospective cohort study
  55. Six-month antibody response to SARS-CoV-2 in healthcare workers assessed by virus neutralization and commercial assays
  56. A novel whole-blood stimulation assay to detect and quantify memory T-cells in COVID-19 patients
  57. LE VIRUS SARS-COV-2 ET SES VARIANTS
  58. Performance of the COVID19SEROSpeed IgM/IgG Rapid Test, an Immunochromatographic Assay for the Diagnosis of SARS-CoV-2 Infection: a Multicenter European Study
  59. A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity
  60. Evaluation of High-Throughput SARS-CoV-2 Serological Assays in a Longitudinal Cohort of Patients with Mild COVID-19: Clinical Sensitivity, Specificity, and Association with Virus Neutralization Test
  61. Live virus neutralization testing in convalescent patients and subjects vaccinated against 19A, 20B, 20I/501Y.V1 and 20H/501Y.V2 isolates of SARS-CoV-2
  62. Bacterial and Viral Infection in Patients Hospitalized for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Implication for Antimicrobial Management and Clinical Outcome
  63. Longitudinal Study of Viral and Bacterial Contamination of Hospital Pediatricians’ Mobile Phones
  64. Evaluation ofin vitroactivity of copper gluconate against SARS-CoV-2 using confocal microscopy-based high content screening
  65. Assessing the safety and pharmacokinetics of the anti-HIV monoclonal antibody CAP256V2LS alone and in combination with VRC07-523LS and PGT121 in South African women: study protocol for the first-in-human CAPRISA 012B phase I clinical trial
  66. Brief comparative evaluation of six open one-step RT-qPCR mastermixes for the detection of SARS-CoV-2 RNA using a Taqman probe
  67. Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound?
  68. SARS-CoV-2 infection: advocacy for training and social distancing in healthcare settings
  69. Evaluation of high-throughput SARS-CoV-2 serological assays in a longitudinal cohort of mild COVID-19 patients: sensitivity, specificity and association with virus neutralization test
  70. Vaccination for Human Papillomavirus: an historic and bibliometric study
  71. COVID-19 and Guillain-Barré syndrome: Response
  72. Povidone Iodine: Properties, Mechanisms of Action, and Role in Infection Control and Staphylococcus aureus Decolonization
  73. Recurrence or Relapse of COVID‐19 in Older Patients: A Description of Three Cases
  74. Cytomegalovirus and Inflammatory Bowel Diseases (IBD) with a Special Focus on the Link with Ulcerative Colitis (UC)
  75. COVID-19 may induce Guillain–Barré syndrome
  76. Strategy using a new antigenic test for rapid diagnosis of Streptococcus pneumoniae infection in respiratory samples from children consulting at hospital
  77. Strategy using a new antigenic test for rapid diagnosis of Streptococcus pneumoniae infection in respiratory samples from children consulting at hospital
  78. Validation of a New Rapid Detection Test for Detection of Neisseria meningitidis A/C/W/X/Y Antigens in Cerebrospinal Fluid
  79. Strategy using a new antigenic test for rapid diagnosis of Streptococcus pneumoniae infection in respiratory samples from children consulting at hospital
  80. Listeria monocytogenes-associated endovascular infections: A study of 71 consecutive cases
  81. Tick-Borne Encephalitis in Auvergne-Rhône-Alpes Region, France, 2017–2018
  82. Analytical performances of the BD Veritor™ System for the detection of respiratory syncytial virus and influenzaviruses A and B when used at bedside in the pediatric emergency department
  83. Case report: Recurrent peripheral facial paralysis following two influenza vaccinations in 2009 and 2016
  84. Interplay of nasal and rectal carriage of Staphylococcus aureus in intensive care unit patients
  85. Human herpesvirus 6 infection after autologous stem cell transplantation: A multicenter prospective study in adult patients
  86. Impact of bedside diagnosis of influenza in the paediatric emergency ward
  87. A serum protein factor mediates maturation and apoB-association of HCV particles in the extracellular milieu
  88. Construction and validation of EGFP-expressingStaphylococcus aureusclinical strains for adhesion and internalization assays on epithelial cells
  89. Comparison of the Fully Automated FilmArray BCID Assay to a 4-Hour Culture Test Coupled to Mass Spectrometry for Day 0 Identification of Microorganisms in Positive Blood Cultures
  90. Impact of HIV-1 primary drug resistance on the efficacy of a first-line antiretroviral regimen in the blood of newly diagnosed individuals in Bamako, Mali
  91. HaCaT epithelial cells as an innovative novel model of rhinovirus infection and impact of clarithromycin treatment on infection kinetics
  92. Staphylococcus aureus colonization and non-influenza respiratory viruses: Interactions and synergism mechanisms
  93. Intracellular activity of antimicrobial compounds used for Staphylococcus aureus nasal decolonization
  94. Transfusion-associated hazards: A revisit of their presentation
  95. Relationship between human immunodeficiency virus (HIV-1) infection and chronic periodontitis
  96. Platelet toll-like receptors are crucial sensors of infectious danger moieties
  97. Hospital-acquired infections documented by repeated annual prevalence surveys over 15 years
  98. Decolonization of Staphylococcus aureus carriage
  99. Epidemiology and clinical relevance of Staphylococcus aureus intestinal carriage: a systematic review and meta-analysis
  100. Acetylsalicylic acid differentially limits the activation and expression of cell death markers in human platelets exposed to Staphylococcus aureus strains
  101. Carbapenemase-producing Acinetobacter baumannii : An outbreak report with special highlights on economic burden
  102. Humoral responses against HIV in male genital tract
  103. Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study
  104. Natural non-homologous recombination led to the emergence of a duplicated V3-NS5A region in HCV-1b strains associated with hepatocellular carcinoma
  105. Performance and economic evaluation of the molecular detection of pathogens for patients with severe infections: the EVAMICA open-label, cluster-randomised, interventional crossover trial
  106. Response to Zidar and Tepes
  107. Prevalence of Chlamydophila pneumoniae and Mycoplasma pneumoniae IgM and IgG antibodies in Tunisian patients presenting with exacerbation of chronic obstructive pulmonary disease
  108. NF-κB Links TLR2 and PAR1 to Soluble Immunomodulator Factor Secretion in Human Platelets
  109. Visualization of X4- and R5-Tropic HIV-1 Viruses Expressing Fluorescent Proteins in Human Endometrial Cells: Application to Tropism Study
  110. Molecular Testing for Human Imunodeficiency Virus
  111. A tribute to Frédéric Morinet: Humanist and dedicated scientist
  112. Agents Associated with Sexually Transmitted Infections
  113. Properties of donated red blood cell components from patients with hereditary hemochromatosis
  114. Corrigendum to “Contamination of healthcare workers' mobile phones by epidemic viruses” [Clin Microbiol Infect (2016) 456.e1–456.e6]
  115. Medico-economic impact of the rapid diagnosis of influenza in paediatric emergency department by using a new sensitive chromatographic immunoassay
  116. Mobile phones of paediatric senior physicians are highly contaminated with viral genomes of several epidemic viruses during the winter season
  117. Clinical severity and molecular characteristics of circulating and emerging rotaviruses in young children attending hospital emergency departments in France
  118. Prospective evaluation of RT-PCR on sputum versus culture, urinary antigens and serology for Legionnaire's disease diagnosis
  119. The infectious risks in blood transfusion as of today – A no black and white situation
  120. Major influence of CD4 count at the initiation of cART on viral and immunological reservoir constitution in HIV-1 infected patients
  121. Persistent But Not Replicating HIV-1 Cell-Associated DNA in Semen of Long-Term ART Experienced Men
  122. Contamination of healthcare workers' mobile phones by epidemic viruses
  123. Identifying Hemodialysis Patients With the Highest Risk of Staphylococcus aureus Endogenous Infection Through a Simple Nasal Sampling Algorithm
  124. Distribution of Cytomegalovirus DNA Load in the Inflamed Colon of Ulcerative Colitis Patients
  125. Transfusion-related acute lung injury: transfusion, platelets and biological response modifiers
  126. How can non-nucleated platelets be so smart?
  127. Platelets and their immune role in anti-infective immunity
  128. Plasma therapy against infectious pathogens, as of yesterday, today and tomorrow
  129. Nouveaux risques viraux en transfusion sanguine à l’horizon 2016
  130. Cytomegalovirus and ulcerative colitis: Place of antiviral therapy
  131. The Genotyping Resistance Profile of the <b><i>Pol</i></b> Gene Detected in Blood of Newly Diagnosed HIV-Positive Men Is Durably Archived in the Gut Whatever the Time of Initiation of cART
  132. Infection par le virus de l’immunodéficience humaine
  133. Sequence Variation in Amplification Target Genes and Standards Influences Interlaboratory Comparison of BK Virus DNA Load Measurement
  134. Platelet components associated with adverse reactions: predictive value of mitochondrial DNA relative to biological response modifiers
  135. European surveillance for enterovirus D68 during the emerging North-American outbreak in 2014
  136. Corrigendum to “Presentation at ESCV 2015: Poster 2 rapid molecular detection of dengue and chikungunya viruses on the BD MAX platform” [J. Clin. Virol. 70 (2015) S102–S103]
  137. Trypanosoma-Cruzi Cross-Reactive Antibodies Longitudinal Follow-Up: A Prospective Observational Study in Hematopoietic Stem Cell Transplantation
  138. Rapid molecular detection of dengue and chikungunya viruses on the BD MAX platform
  139. Identification of a duplicated V3 domain in NS5A associated with cirrhosis and hepatocellular carcinoma in HCV-1b patients
  140. Transfusion et inflammation : hier – aujourd’hui – demain
  141. Infliximab Does Not Worsen Outcomes During Flare-ups Associated with Cytomegalovirus Infection in Patients with Ulcerative Colitis
  142. Molecular dynamics of Staphylococcus aureus nasal carriage in Hajj pilgrims
  143. Specific activation, signalling and secretion profiles of human platelets following PAR-1 and PAR-4 stimulation
  144. Evaluation of New bioMérieux Chromogenic CPS Media for Detection of Urinary Tract Pathogens
  145. Does pharyngeal sampling improve the detection of nasopharyngeal persistent carriers of Staphylococcus aureus?
  146. Human platelets and their capacity of binding viruses: meaning and challenges?
  147. Development and Validation of a Laboratory-Developed Multiplex Real-Time PCR Assay on the BD Max System for Detection of Herpes Simplex Virus and Varicella-Zoster Virus DNA in Various Clinical Specimens
  148. Platelets and Infections – Complex Interactions with Bacteria
  149. Transfusion sanguine : en toute sécurité infectieuse
  150. LPS stimulation of purified human platelets is partly dependent on plasma soluble CD14 to secrete their main secreted product, soluble-CD40-Ligand
  151. Is transfusion-transmitted dengue fever a potential public health threat?
  152. The inflammatory role of platelets via their TLRs and Siglec receptors
  153. The Signaling Role of CD40 Ligand in Platelet Biology and in Platelet Component Transfusion
  154. Non-leukodepleted red blood cell transfusion in sepsis patients: beyond oxygenation, is there a risk of inflammation?
  155. Are polymorphisms of the immunoregulatory factor CD40LG implicated in acute transfusion reactions?
  156. Authors' reply: Reduction of the use of antimicrobial drugs following the rapid detection of Streptococcus agalactiae in the vagina at delivery by real‐time PCR assay
  157. Are the risk factors associated with Staphylococcus aureus nasal carriage in patients the same than in healthy volunteers? Data from a cohort of patients scheduled for orthopedic material implantation
  158. Direct typing of human enteroviruses from wastewater samples
  159. Role of Siglec-7 in Apoptosis in Human Platelets
  160. Partial sequencing of the VP2 capsid gene for direct enterovirus genotyping in clinical specimens
  161. Functional Balance between the Hemagglutinin and Neuraminidase of Influenza A(H1N1)pdm09 HA D222 Variants
  162. Epidemiology and microbiological investigations of community-acquired pneumonia in children admitted at the emergency department of a university hospital
  163. Study of Coxsackie B viruses interactions with Coxsackie Adenovirus receptor and Decay-Accelerating Factor using Human CaCo-2 cell line
  164. A Computerized Prediction Model of Hazardous Inflammatory Platelet Transfusion Outcomes
  165. Autoimmune N-methyl-D-aspartate receptor encephalitis is a differential diagnosis of infectious encephalitis
  166. Impact of the level of pre-ART CD4+ T cells in blood on the rectal HIV reservoir in long-term treated men (VIRECT study)
  167. Kinetics of release of antiretroviral drugs through a silicone intravaginal ring
  168. Flow cytometry analysis of coxsackievirus B receptors expression in human CaCo-2 cells
  169. Use of Vaginal Rings Charged with Antiviral Drugs for Preventing HIV Infection in Women
  170. Evaluation of the New Brilliance GBS Chromogenic Medium for Screening of Streptococcus agalactiae Vaginal Colonization in Pregnant Women
  171. Health care-associated hepatitis C virus infection
  172. Semen lactoferrin promotes CCL20 production by epithelial cells: Involvement in HIV transmission
  173. Quantification of cytomegalovirus viral load
  174. Comparison of SPF10 real-time PCR and conventional PCR in combination with the INNO-LiPA HPV Genotyping Extra assay for the detection and typing of human papillomavirus in cervical samples
  175. Immunologic nonresponders and T-regulatory cells in HIV-1 infection
  176. Detection and clinical relevance ofStaphylococcus aureusnasal carriage: an update
  177. Letter to the Editor
  178. Staphylococcal vaccine development: review of past failures and plea for a future evaluation of vaccine efficacy not only on staphylococcal infections but also on mucosal carriage
  179. Potential contribution of saliva to the sexual transmission of HIV through the secretion of CCL20 by genital epithelial cells
  180. Anti-Trypanosoma cruzi Cross-Reactive Antibodies Detected at High Rate in Non-Exposed Individuals Living in Non-Endemic Regions: Seroprevalence and Association to Other Viral Serologies
  181. Molecular HIV screening
  182. Comparative Evaluation of Six Commercialized Multiplex PCR Kits for the Diagnosis of Respiratory Infections
  183. Immune‐reactive soluble OX40 ligand, soluble CD40 ligand, and interleukin‐27 are simultaneously oversecreted in platelet components associated with acute transfusion reactions
  184. Acute encephalitis associated to a respiratory infection due to Chlamydophila pneumoniae
  185. Identification of infected corneal epithelial cells using an innovative in vivo fluorescent multilaser confocal microscope: Proofs of concept
  186. Evaluation of the new CE-IVD marked BD MAX Cdiff Assay for the detection of toxigenic Clostridium difficile harboring the tcdB gene from clinical stool samples
  187. Highly Active Antiretroviral Therapy Alters Inflammation Linked to Platelet Cytokines in HIV-1-Infected Patients
  188. Encephalitis due to Mycobacterium tuberculosis in France
  189. Statut vaccinal des médecins généralistes dans le département de la Loire, France
  190. Incidence des gastroentérites à rotavirus chez les enfants de moins de cinq ans consultant un pédiatre ou un médecin généraliste en France
  191. Reduction of the use of antimicrobial drugs following the rapid detection ofStreptococcus agalactiaein the vagina at delivery by real‐timePCRassay
  192. Transfusion sanguine et inflammation
  193. Nosocomial Meningitis due toStreptoccus salivariusLinked to the Oral Flora of an Anesthesiologist
  194. Human papillomavirus and head and neck squamous cell carcinomas in the South-East of France: prevalence, viral expression, and prognostic implications
  195. Investigative In Vitro Study about Red Blood Cell Concentrate Processing and Storage
  196. Bench-to-bedside review: Platelets and active immune functions - new clues for immunopathology?
  197. Contribution of activated platelets to plasma IL-27 levels
  198. Human platelets can discriminate between various bacterial LPS isoforms via TLR4 signaling and differential cytokine secretion
  199. Epidemiology of infectious encephalitis, differences between a prospective study and hospital discharge data
  200. Comparative evaluation of the QIAsymphony RGQ system with the easyMAG/R-gene combination for the quantitation of cytomegalovirus DNA load in whole blood
  201. Impact des gastroentérites à Rotavirus chez les enfants de moins de cinq ans hospitalisés ou consultant en services d’urgences en France
  202. Acute varicella zoster encephalitis without evidence of primary vasculopathy in a case-series of 20 patients
  203. Management of cytomegalovirus infection in inflammatory bowel diseases
  204. Prevalence of Cytomegalovirus Infection in Steroid-refractory Crohnʼs Disease
  205. An algorithm based on one or two nasal samples is accurate to identify persistent nasal carriers of Staphylococcus aureus
  206. In vitro study of the trans-epithelial crossing of HIV-1 through the female genital mucosa and of the role of epithelial cells in the selection of CCR5-tropic virus
  207. Nosocomial transmission of NDM-1-producing Escherichia coli within a non-endemic area in France
  208. Selective transmigration of monocyte-associated HIV-1 across a human cervical monolayer and its modulation by seminal plasma
  209. Quantification by Real-Time PCR Assay of Staphylococcus aureus Load: a Useful Tool for Rapidly Identifying Persistent Nasal Carriers
  210. Long-term Outcome of Patients Presenting With Acute Infectious Encephalitis of Various Causes in France
  211. Molecular Characterization of Human Enteroviruses in the Central African Republic: Uncovering Wide Diversity and Identification of a New Human Enterovirus A71 Genogroup
  212. Current and future microbicide approaches aimed at preventing HIV infection in women
  213. Revisiting the B-cell compartment in mouse and humans: more than one B-cell subset exists in the marginal zone and beyond
  214. Transmission by super-spreading event of pandemic A/H1N1 2009 influenza during road and train travel
  215. Listeria monocytogenes encephalitis in France
  216. Cytomegalovirus Load in Inflamed Intestinal Tissue Is Predictive of Resistance to Immunosuppressive Therapy in Ulcerative Colitis
  217. Complexes between nuclear factor-κB p65 and signal transducer and activator of transcription 3 are key actors in inducing activation-induced cytidine deaminase expression and immunoglobulin A production in CD40L plus interleukin-10-treated human blood ...
  218. Chlorine dioxide for Legionella spp. disinfection: a danger for cross-linked polyethylene pipes?
  219. Herpes simplex encephalitis and management of acyclovir in encephalitis patients in France
  220. Risques viraux émergents en transfusion sanguine
  221. Evaluation of an immunomagnetic separation assay in combination with cultivation to improveLegionella pneumophilaserogroup 1 recovery from environmental samples
  222. Interpretation of Real-Time PCR Results for Hepatitis C Virus RNA When Viral Load Is Below Quantification Limits
  223. Meningitis in adult patients with a negative direct cerebrospinal fluid examination: value of cytochemical markers for differential diagnosis
  224. Longitudinal Evaluation of the Efficacy of Heat Treatment Procedures againstLegionellaspp. in Hospital Water Systems by Using a Flow Cytometric Assay
  225. HIV-1 Load Comparison Using Four Commercial Real-Time Assays
  226. Extremely Drug-ResistantCitrobacter freundiiIsolate Producing NDM-1 and Other Carbapenemases Identified in a Patient Returning from India
  227. In Vitro Evaluation of Viability, Integrity, and Inflammation in Genital Epithelia upon Exposure to Pharmaceutical Excipients and Candidate Microbicides
  228. Better Detection of Staphylococcus aureus Nasal Carriage by Use of Nylon Flocked Swabs
  229. Toll‐like receptor 4 signal transduction in platelets: novel pathways
  230. Place des microbicides vaginaux dans la prévention de l’infection par le virus de l’immunodéficience humaine
  231. Erratum
  232. Septic shock due to Legionella pneumophila serogroup 2: usefulness of molecular biology for diagnosis, treatment and epidemiological investigation
  233. Multiplex PCR theranostics of severe respiratory infections
  234. Is nasal carriage of Staphylococcus aureus the main acquisition pathway for surgical-site infection in orthopaedic surgery?
  235. Multicenter evaluation of the ENTEROVIRUS R-gene™ real-time RT-PCR assay for the detection of enteroviruses in clinical specimens
  236. Infectious Encephalitis in France in 2007: A National Prospective Study
  237. Enterovirus-related activation of the cardiomyocyte mitochondrial apoptotic pathway in patients with acute myocarditis
  238. Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapy
  239. P10-09. Altered release of RANTES from human, normal platelets: contribution of distinct HIV-1MN gp41 peptides
  240. Altered release of regulated upon activation, normal T-cell expressed and secreted protein from human, normal platelets: contribution of distinct HIV-1MN gp41 peptides
  241. Measure of Viral Load by Using the Abbott Real-Time HIV-1 Assay on Dried Blood and Plasma Spot Specimens Collected in 2 Rural Dispensaries in Cameroon
  242. OP6-1 Multicenter evaluation of the ENTEROVIRUS R-gene™ real time RT-PCR assay for the detection of enteroviruses in clinical specimens
  243. Comparative Evaluation of a Commercially Available Automated System for Extraction of Viral DNA from Whole Blood: Application to Monitoring of Epstein-Barr Virus and Cytomegalovirus Load
  244. Construction and tropism characterisation of recombinant viruses exhibiting HIV-1 env gene from seminal strains
  245. Prospective evaluation of the threat related to the use of seminal fractions from hepatitis C virus-infected men in assisted reproductive techniques
  246. Incidence of cancer in children perinatally exposed to nucleoside reverse transcriptase inhibitors
  247. Use of Flow Cytometry To Monitor Legionella Viability
  248. Identification of two subpopulations of purified human blood B cells, CD27− CD23+ and CD27high CD80+, that strongly express cell surface Toll‐like receptor 9 and secrete high levels of interleukin‐6
  249. Direct contact of platelets and their released products exert different effects on human dendritic cell maturation
  250. Toll‐like receptor 4 ligand can differentially modulate the release of cytokines by human platelets
  251. Active Coxsackieviral B Infection Is Associated With Disruption of Dystrophin in Endomyocardial Tissue of Patients Who Died Suddenly of Acute Myocardial Infarction
  252. Multicenter Trials Need To Use the Same Assay for Hepatitis C Virus Viral Load Determination
  253. Basic rationale, current methods and future directions for molecular typing of human enterovirus
  254. Enterovirus in arteriosclerosis: A pilot study
  255. Natural Recombination Event within the Capsid Genomic Region Leading to a Chimeric Strain of Human Enterovirus B
  256. Typing of Human Enterovirus by Partial Sequencing of VP2
  257. Conversion of Prevalence Survey Data on Nosocomial Infections to Incidence Estimates: A Simplified Tool for Surveillance?
  258. Encéphalite aiguë: à propos de 32 enfants vus consécutivement dans un même service de pédiatrie
  259. Désinfection et matériovigilance
  260. Expertise of Laboratories in Viral Load Quantification, Genotyping, and Precore Mutant Determination for Hepatitis B Virus in a Multicenter Study
  261. Analysis of Polymorphism in the Protease and Reverse Transcriptase Genes of HIV Type 1 CRF02-AG Subtypes From Drug-Naive Patients From Saint-Etienne, France
  262. Efficacy of environmental measures to decrease the risk of hospital-acquired aspergillosis in patients hospitalised in haematology wards
  263. Amount of seminal IL-1β positively correlates to HIV-1 load in the semen of infected patients
  264. Magnetic valves as a source of faucet contamination with Pseudomonas aeruginosa?
  265. Bacterial contamination of nonsterile disposable gloves before use
  266. Seminal plasma promotes the attraction of Langerhans cells via the secretion of CCL20 by vaginal epithelial cells: involvement in the sexual transmission of HIV
  267. Unique NS5b Hepatitis C Virus Gene Sequence Consensus Database Is Essential for Standardization of Genotype Determinations in Multicenter Epidemiological Studies
  268. Analysis of the genetic diversity of Legionella by sequencing the 23S-5S ribosomal intergenic spacer region: from phylogeny to direct identification of isolates at the species level from clinical specimens
  269. Enterovirus cardiovascular infection and acute myocardial infarction
  270. HIV and HCV RNA quantification in semen by m2000rt technology
  271. Comparative evaluation of the VIDAS HIV DUO Ultra assay for combined detection of HIV-1 antigen and antibodies to HIV
  272. Development and Evaluation of Chlamylege, a New Commercial Test Allowing Simultaneous Detection and Identification of Legionella, Chlamydophila pneumoniae, and Mycoplasma pneumoniae in Clinical Respiratory Specimens by Multiplex PCR
  273. Épidémiologie des infections nosocomiales à Pseudomonas aeruginosa, Burkholderia cepacia et Stenotrophomonas maltophilia
  274. Recognition of coxsackievirus A by Enterovirus genus-specific immune and molecular markers in experimentally infected suckling mice
  275. Development of three multiplex RT-PCR assays for the detection of 12 respiratory RNA viruses
  276. Comparison of Hepatitis C Virus NS5b and 5' Noncoding Gene Sequencing Methods in a Multicenter Study
  277. Sous-types du virus de l'immunodéficience humaine de type 1 dans une cohorte de sujets dépistés à Saint-Étienne, France, de 1984 à 2003
  278. Editorial
  279. Evaluation of a total core antigen assay for the diagnosis of hepatitis C virus infection in hemodialysis patients
  280. Selective sequestration of X4 isolates by human genital epithelial cells: Implication for virus tropism selection process during sexual transmission of HIV
  281. Association between enterovirus endomyocardial infection and late severe cardiac events in some adult patients receiving heart transplants
  282. Influence of blood prestorage conditions and white blood cell filtration on the bacterial load of blood deliberately inoculated with Gram‐positive and Gram‐negative pathogens
  283. Bacterial risk and sperm cryopreservation
  284. Coxsackievirus B3 replication and persistence in intestinal cells from mice infected orally and in the human CaCo‐2 cell line
  285. Evaluation of a prototype HCV NS5b assay for typing strains of hepatitis C virus isolated from Tunisian haemodialysis patients
  286. Prévalence et incidence élevées de l’infection par le virus de l’hépatite C chez les hémodialysés dans la région Centre-Est de la Tunisie
  287. Validation of safety procedures for the cryopreservation of semen contaminated with hepatitis C virus in assisted reproductive technology
  288. Silent transfusion‐transmitted hepatitis A virus infection in an infant
  289. The procedures of hygiene to control hospital-acquired diarrhoea in paediatric wards: a multicentre audit
  290. Is Nasal Carriage of Methicillin-Resistant Staphylococcus aureus More Prevalent Among Student Healthcare Workers?
  291. Suivi prospectif des diarrhées nosocomiales dans 28 services de pédiatrie du quart Sud-Est de la France au cours d’un trimestre d’hiver
  292. Surveillance Network for Herpes Simplex Virus Resistance to Antiviral Drugs: 3-Year Follow-Up
  293. Detection of IgA inhibiting the interaction between gp120 and soluble CD4 receptor in serum and saliva of HIV-1-infected patients
  294. Detection of enterovirus in human skeletal muscle from patients with chronic inflammatory muscle disease or fibromyalgia and healthy subjects
  295. Contrôle de phénomènes épidémiques dus à des souches de Staphylococcus aureus de sensibilité diminuée aux glycopeptides
  296. Implication potentielle d’étudiants infirmiers dans la transmission de Staphylococcus aureus résistant à la méthicilline lors d’une épidémie nosocomiale
  297. Genotypic and Phenotypic Analysis of Type III Secretion System in a Cohort ofPseudomonas aeruginosaBacteremia Isolates: Evidence for a Possible Association between O Serotypes andexoGenes
  298. Reported Measures of Hygiene and Incidence Rates for Hospital-Acquired Diarrhea in 31 French Pediatric Wards: Is There Any Relationship?
  299. Évaluation de l’intérêt de la spermoculture avant autoconservation de sperme
  300. New PCR Test That Recognizes All Human Prototypes of Enterovirus: Application for Clinical Diagnosis
  301. Implication of a Healthcare Worker With Chronic Skin Disease in the Transmission of an Epidemic Strain of Methicillin-Resistant Staphylococcus aureus in a Pediatric Intensive Care Unit
  302. Multicenter Quality Control for the Detection of Hepatitis C Virus RNA in Seminal Plasma Specimens
  303. Temporal Surveillance of the Humoral Immunity against Influenza Vaccine in the Elderly over 9 Consecutive Years
  304. Pregnancy after safe IVF with hepatitis C virus RNA-positive sperm: Case report
  305. Detection and Characterization of Hepatitis C Virus RNA in Seminal Plasma and Spermatozoon Fractions of Semen from Patients Attempting Medically Assisted Conception
  306. Detection of GB virus C/hepatitis G virus in semen and saliva of HIV type-1 infected men
  307. Reduction of Yersinia enterocolitica load in deliberately inoculated blood: the effects of blood prestorage temperature and WBC filtration
  308. Place des viroses respiratoires dans les hyperthermies de sujets âgés hospitalisés au cours d’une saison hivernale
  309. Prospective study of nosocomial colonization and infection due to Pseudomonas aeruginosa in mechanically ventilated patients
  310. Nosocomial Colonization of Premature Babies With Klebsiella oxytoca: Probable Role of Enteral Feeding Procedure in Transmission and Control of the Outbreak With the Use of Gloves
  311. Stratégie de prévention du risque de légionellose nosocomiale à l'hôpital Nord, CHU De Saint-Etienne
  312. Compartmentalization of HIV-1 according to antiretroviral therapy: viral loads are correlated in blood and semen but poorly in blood and saliva
  313. Stratégie de prévention du risque aspergillaire au CHU de Saint-Étienne
  314. Neutralization of Human Immunodeficiency Virus Type 1 (HIV‐1) Mediated by Parotid IgA of HIV‐1–Infected Patients
  315. Enteroviral Capsid Protein VP1 Is Present in Myocardial Tissues From Some Patients With Myocarditis or Dilated Cardiomyopathy
  316. Les infections à entérovirus du nourrisson de moins de trois mois
  317. Réponse à la vaccination par l'anatoxine tétanique chez la femme âgée: étude prospective sur 42 mois
  318. Variations in the recognition of echovirus type 11 strains by a group-specific anti-VP1 monoclonal antibody
  319. Prevalence of GBV‐C/hepatitis G virus RNA and E2 antibody among subjects infected with human immunodeficiency virus type 1 after parenteral or sexual exposure
  320. Prevalence of GBV-C/hepatitis G virus RNA and E2 antibody among subjects infected with human immunodeficiency virus type 1 after parenteral or sexual exposure
  321. Aplastic Anemia After Mycoplasma pneumoniae Infection
  322. High Sensitivity and Specificity of Serum Procalcitonin Levels in Adults with Bacterial Meningitis
  323. Investigation of a Nosocomial Outbreak Due toSerratia marcescensin a Maternity Hospital
  324. COXSACKIEVIRUSES (PICORNAVIRIDAE)
  325. Nosocomial legionellosis outbreak over a three-year period: investigation and control
  326. Nucleotide sequence of an attenuated mutant of coxsackievirus B3 compared with the cardiovirulent wildtype: assessment of candidate mutations by analysis of a revertant to cardiovirulence
  327. Comparison of a rapid culture method combining an immunoperoxidase test and a group specific anti-VP1 monoclonal antibody with conventional virus isolation techniques for routine detection of enteroviruses in stools
  328. Humoral immune response within the lung in HIV-1 infection
  329. Detection of coxsackievirus B3 in intestinal tissue of orally-infected mice by a standardized RT-PCR assay
  330. Quantification of IgA and IgG and specificities of antibodies to viral proteins in parotid saliva at different stages of HIV-1 infection
  331. Multicenter evaluating of a commercially available PCR assay for diagnosing enterovirus infection in a panel of cerebrospinal fluid specimens
  332. CLEAR EVIDENCE OF THE EXISTENCE OF HEALTHY CARRIERS OF HEPATITIS C VIRUS AMONG RENAL TRANSPLANT RECIPIENTS
  333. Molecular typing of nosocomial strains of Legionella pneumophila by arbitrarily primed PCR
  334. HCV liver disease in renal transplantation: a clinical and histological study
  335. Structure, genomic organization, replication and variability of hepatitis C virus
  336. Arbitrarily-primed PCR confirms the differentiation of strains ofUreaplasma urealyticuminto two biovars
  337. Epidemiologic and molecular investigations of genital mycoplasmas from women and neonates at delivery
  338. Evaluation of an enterovirus group-specific anti-VP1 monoclonal antibody, 5-D8/1, in comparison with neutralization and PCR for rapid identification of enteroviruses in cell culture
  339. Characterization of Nosocomial Strains of Enterobacter aerogenes by Arbitrarily Primed-PCR Analysis and Ribotyping
  340. Is there IgA of gut mucosal origin in the serum of HIV1 infected patients?
  341. Differentiation of Pseudomonas aeruginosa strains by ribotyping: high discriminatory power by using a single restriction endonuclease
  342. Arbitrarily primed PCR, ribotyping, and plasmid pattern analysis applied to investigation of a nosocomial outbreak due to Enterobacter cloacae in a neonatal intensive care unit
  343. Is there a relationship between malnutrition, inflammation, and post‐vaccinal antibody response to influenza viruses in the elderly?
  344. Ventilator temperature sensors: an unusual source of Pseudomonas cepacia in nosocomial infection
  345. Transient erythroblastopenia of childhood presenting with echovirus 11 infection
  346. Characterization of unrelated strains of Staphylococcus schleiferi by using ribosomal DNA fingerprinting, DNA restriction patterns, and plasmid profiles
  347. Prognostic value of serum immunoglobulin A antibodies to pol gene products during HIV-1 infection
  348. Genotypic homogeneity of nosocomialPseudomonas aeruginosa O12 strains demonstrated by analysis of protein profiles, DNA fingerprints and rRNA gene restriction patterns
  349. Role of Influenza Vaccination in the Elderly during an Epidemic of A/H1N1 Virus in 1988–1989: Clinical and Serological Data
  350. Entérovirose et manifestations cliniques systémiques avec syndrome inflammatoire prolongé: association avec une persistance des anticorps IGM spécifiques
  351. Comparison of excretory/secretory and circulating antigens of Toxoplasma gondii by enzyme immunoassay and immunoblotting
  352. Evidence for T‐cell involvement during the acute phase of echo virus meningitis
  353. A 44,000 glycoprotein is involved in the attachment of echovirus-11 onto susceptible cells
  354. Evaluation of four methods for rapid detection of adenovirus
  355. Lumbosacral meningoradiculitis associated with Chlamydia pneumoniae infection.
  356. Immunoblotting patterns with Mycoplasma pneumoniae of serum specimens from infected and non-infected subjects
  357. Protective effect of a monoclonal antibody specific for an echovirus cellular receptor in human fibroblast and simian kidney cell lines
  358. Emergence of quinolone-imipenem cross-resistance in Pseudomonas aeruginosa after flooroqmnolone therapy
  359. Antibodies to Epstein‐Barr virus and cytomegalovirus in relation to CD4 cell number in human immunodeficiency virus 1 infection
  360. Competition binding studies with biotinylated echovirus 11 in cytofluorimetry analysis
  361. Gastroentérites nosocomiales à rotavirus du groupe A en pédiatrie hospitalière
  362. Kinetic of circulating antigens by capture ELISA and immunoblotting in murine toxoplasmosis
  363. Toxoplasma gondii antigens: Analysis by SDS-PAGE and immunoblotting; Relation with circulating antigens
  364. Pharmacokinetic evidence of imipenem efficacy in the treatment of Klebsiella pneumonae nosocomial meniogitis
  365. Detection of immunoglobulin G, M, and A antibodies to enterovirus structural proteins by immunoblot technique in echovirus type 4-infected patients
  366. Comparison of early-antigen immunoperoxidase test in 18-h cultures and conventional virus isolation for the routine detection of cytomegalovirus in urine specimens
  367. Nosocomial Infection with Legionella pneumophila Serogroup 1 and 8 in a Neonate
  368. Detection of neutralizing igm antibodies in the diagnosis of enterovirus infections
  369. Comparative evaluation of immunoglobulin M neutralizing antibody response in acute-phase sera and virus isolation for the routine diagnosis of enterovirus infection
  370. Characterization of a non-structural 147-kDa precursor polypeptide of echovirus 33 and its immunogenicity in man
  371. Ganciclovir Therapy of Symptomatic Cytomegalovirus Infection in Renal Transplant Recipients
  372. Detection of antibodies against initial polypeptides in patients infected with an enterovirus (EV-33)
  373. Commercial monoclonal antibodies for rapid detection of respiratory syncytial virus by direct immunofluorescence
  374. ACUTE ADENOVIRUS ENCEPHALITIS DIAGNOSED BY PROLONGED INTRATHECAL ANTIBODY PRODUCTION
  375. Rapid diagnosis of echovirus 33 infection by neutralizing specific IgM antibody
  376. Role of Sex and Early Interferon Production in the Susceptibility of Mice to Encephalomyocarditis Virus
  377. Characteristics of Autoantibodies to Human Interferon in a Patient with Varicella-Zoster Disease
  378. Absolute frequency measurements of the 0002-0000, 2001-0000, and 1201-0000 bands of N2O by heterodyne spectroscopy
  379. Interferon- /beta Is Not Involved in Resistance of Mice to Reinfection with Encephalomyocarditis Virus
  380. Etude des antigènes HLA, des allotypes Gm et des sous populations lymphocytaires Tchez un groupe de malades ayant un test de coombs positif sous traitement à l'alpha méthyldopa